RxDoctor Payments Data

William Engasser, MD

Orthopaedic Surgery · Edina, MNNPI 1366856445

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (34.6%), grants and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 42.8% of the total.

$36,823in general payments, 2019–2025

Across 93 payments — averaging $395.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$16K
  • Medical Device Business Services, Inc.$8K
  • Responsive Arthroscopy Inc$6K
  • Paragon 28, Inc.$2K
  • Gemini Medical LLC$1K
  • Stryker$985
  • plus $2K from 11 others
$38,194in research payments, 2019–2025

Across 3 payments — averaging $12,731 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Paragon 28, Inc.$38K

What the payments were for

  • Consulting fees$12,72935%
  • Speaking & faculty fees$3,82510%
  • Grants$10,00027%
  • Travel & lodging$4,10011%
  • Food & beverage$4,53112%
  • Education$1,6384%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,823 in reported general payments places this provider in the 85th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024
$114,308
Medicare patients
284
Services billed
1,269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin14$129
Meloxicam33$92
Cephalexin14$65

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Edina

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →